BioSpace News Archive

Valneva SE, a specialty vaccine company, reported consolidated financial results for the first nine months of the year, ended September 30, 2023.

Strong progress across obesity pipeline, first PDUFA date for dasiglucagon in CHI in 2023 and solid financial position.

Oncocyte Corporation, a precision diagnostics company, reported financial results for the third quarter of 2023, ended September 30, 2023.

Sol-Gel Technologies, Ltd. announced financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, announced third quarter 2023 financial results and summarized recent developments.

Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc. announce a new worldwide license agreement and expansion of existing licenses for the development and commercialization of cell therapies derived from iPSCs for the treatment of autoimmune and inflammatory diseases, including type 1 diabetes, multiple sclerosis, lupus, and rheumatoid arthritis.

Clinical Laserthermia Systems Americas, Inc., a leading provider of office-based, focal laser ablation systems for urologists, announced that KASRAEIAN Urology located in Jacksonville, FL, will begin treating prostate cancer patients using the TRANBERG™ Thermal Therapy System to provide focal laser ablation treatments.

Century Therapeutics, Inc., an innovative biotechnology company developing induced pluripotent stem cell -derived cell therapies in immuno-oncology, reported financial results and business highlights for the third quarter ended September 30, 2023.

Krystal Biotech, Inc. announced that the Company will participate in the Stifel 2023 Healthcare Conference in New York.

IntelGenx Technologies Corp. reported financial results for the third quarter ended September 30, 2023.